Nectar Lifesciences announces equity buyback, appoints new finance director

Nectar Lifesciences Ltd. announced a buyback of up to 30,000,000 equity shares, representing up to 13.38% of its total paid-up equity capital as of March 31, 2025. The buyback, valued at INR 81,00,00,000, will be conducted at INR 27 per share via a "tender offer" route. The record date for determining eligible shareholders for the buyback has been set for December 24, 2025, with promoters stating their intention not to participate. Master Capital Services Limited has been appointed as the merchant banker for this process.

In parallel, the company has appointed Sushil Kapoor as an additional director and wholetime director, designated as director (finance), for a three-year term effective December 4, 2025. Kapoor, 67, brings over 38 years of financial and accounting experience, having held key managerial positions in various companies. His appointment will be subject to shareholder approval through a postal ballot process.

The board meeting, which concluded on December 3, 2025, also included disclosures on the pre and post-buyback shareholding pattern as of November 28, 2025. Nectar Lifesciences will disclose the actual number of shares bought back and the resulting percentage of paid-up capital after the completion of the buyback.